PHARMACOSMOS A/S
CVR number: 15517085
Rørvangsvej 30, 4300 Holbæk
tel: 59485959
Income statement (mDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | 609.06 | 782.21 | 876.81 | 1 104.17 | 1 613.14 |
Other operating income | 4.73 | 300.19 | |||
Costs of manufacturing | - 403.31 | - 367.78 | |||
Gross profit | 328.86 | 464.89 | 545.46 | 700.85 | 1 245.36 |
Costs of management | - 244.19 | - 295.58 | |||
Costs of distribution | - 150.59 | - 174.74 | |||
Other operating expenses | -33.85 | -95.51 | |||
EBIT | 128.28 | 219.34 | 210.95 | 272.23 | 679.52 |
Other financial income | 49.69 | 152.07 | |||
Other financial expenses | - 104.78 | 29.85 | |||
Net income from associates (fin.) | -55.95 | -63.02 | |||
Pre-tax profit | 59.60 | - 118.52 | 170.04 | 165.92 | 1 038.91 |
Income taxes | -51.64 | - 249.21 | |||
Net earnings | 59.60 | - 118.52 | 170.04 | 114.27 | 789.70 |
Assets (mDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Development expenditure | 100.70 | 58.73 | |||
Intangible assets total | 100.70 | 58.73 | |||
Machinery and equipment | 4.35 | 6.75 | |||
Tangible assets total | 4.35 | 6.75 | |||
Holdings in group member companies | 107.21 | 85.87 | |||
Other receivables | 1 354.81 | 1 478.56 | 1 590.17 | ||
Investments total | 1 354.81 | 1 478.56 | 1 590.17 | 107.21 | 85.87 |
Long term receivables total | |||||
Raw materials and consumables | 28.79 | 29.22 | |||
Finished products/goods | 118.55 | 140.00 | |||
Inventories total | 147.34 | 169.23 | |||
Current trade debtors | 113.64 | 236.47 | |||
Current amounts owed by group member comp. | 606.65 | 1 033.20 | |||
Prepayments and accrued income | 3.88 | 6.28 | |||
Current other receivables | 7.11 | 8.24 | |||
Current deferred tax assets | 1.74 | ||||
Short term receivables total | 731.29 | 1 285.94 | |||
Other current investments | 235.56 | 947.65 | |||
Cash and bank deposits | 427.00 | 103.52 | |||
Cash and cash equivalents | 662.56 | 1 051.17 | |||
Balance sheet total (assets) | 1 354.81 | 1 478.56 | 1 590.17 | 1 753.45 | 2 657.70 |
Equity and liabilities (mDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 894.44 | 670.68 | 807.47 | 101.00 | 101.00 |
Other reserves | 78.55 | 45.81 | |||
Retained earnings | -59.60 | 118.52 | - 170.04 | 560.77 | 699.27 |
Profit of the financial year | 59.60 | - 118.52 | 170.04 | 114.27 | 789.70 |
Shareholders equity total | 894.44 | 670.68 | 807.47 | 854.59 | 1 635.78 |
Provisions | 7.06 | ||||
Non-current loans from credit institutions | 391.62 | 327.67 | |||
Non-current liabilities total | 391.62 | 327.67 | |||
Current loans from credit institutions | 41.41 | 63.69 | |||
Current trade creditors | 59.22 | 59.80 | |||
Current owed to group member | 326.40 | 492.12 | |||
Other non-interest bearing current liabilities | 24.67 | 35.16 | |||
Accruals and deferred income | 48.48 | 43.48 | |||
Current liabilities total | 500.18 | 694.24 | |||
Balance sheet total (liabilities) | 894.44 | 670.68 | 807.47 | 1 753.45 | 2 657.70 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.